This will in turn help lower blood sugar levels, which will help the body in numerous ways
These injections are typically administered in so-called problem areas such as the chin, legs, upper arms and abdomen
Researchers started 1,613 adults in the trial on 1 mg of orforglipron and increased the dose every four weeks until patients received 6 mg, 12 mg, and 36 mg, while other patients received a placebo
Looking at the 18% of adults who have ever used GLP-1 agonist drugs, most report using them to treat a chronic condition, while a smaller share say they used them solely to lose weight
Obtaining injections outside regulated NHS settings may involve inappropriate dosing, lack of monitoring, non-sterile technique, and unnecessary financial cost without clinical benefit